Meta Q1 2025 earnings: AI revenue momentum meets European regulatory storm

Pallavi Madhiraju- May 1, 2025 0

Meta’s Q1 2025 profit surged 35%, powered by AI and ads. Learn how its battle with EU regulators could impact its revenue and product roadmap. Read More

FILSPARI secures full European approval: A major breakthrough for IgA nephropathy patients

Pallavi Madhiraju- April 29, 2025 0

Find out how FILSPARI’s full EU approval marks a major step for IgA nephropathy treatment and strengthens CSL Vifor and Travere Therapeutics’ rare disease focus. Read More

ACIP expands Pfizer’s ABRYSVO vaccine guidance to include at-risk adults aged 50–59

Pallavi Madhiraju- April 21, 2025 0

Pfizer's RSV vaccine ABRYSVO now recommended for at-risk adults aged 50–59. Learn what it means for public health and Pfizer’s expanding vaccine portfolio. Read More

Europe’s trillion-euro AI gamble: Inside the EU’s bold plan to lead the global artificial intelligence race

Pallavi Madhiraju- April 9, 2025 0

Find out how the European Commission’s AI Continent Action Plan aims to transform Europe into a global AI powerhouse through data, talent, and infrastructure. Read More

EU hits back: Retaliatory tariffs on U.S. goods to start April 15 amid steel and aluminium dispute

Pallavi Madhiraju- April 9, 2025 0

EU to impose tariffs on U.S. goods from April 15 in response to steel and aluminium duties. Find out how this move could reshape global ... Read More

Imfinzi gains EU approval in resectable NSCLC, bolstering AstraZeneca’s oncology pipeline

Pallavi Madhiraju- April 4, 2025 0

AstraZeneca’s Imfinzi-based regimen approved in the EU to cut lung cancer recurrence by 32%—learn how this could redefine early-stage NSCLC treatment. Read More

EU approves Enhertu as first HER2-targeted therapy for HR-positive, HER2-low metastatic breast cancer

Pallavi Madhiraju- April 4, 2025 0

Discover how Enhertu’s EU approval is transforming care for HR-positive, HER2-low and HER2-ultralow breast cancer, and what it means for AstraZeneca’s future. Read More

Celltrion gains EC approval for Avtozma, a RoActemra biosimilar for autoimmune diseases

Pallavi Madhiraju- February 24, 2025 0

Celltrion has received marketing authorization from the European Commission (EC) for Avtozma, a biosimilar to RoActemra (tocilizumab), expanding the company’s footprint in the immunology and ... Read More

Baltic Sea mystery: Who is behind the latest attack on Europe’s internet?

Pallavi Madhiraju- February 22, 2025 0

Swedish authorities have launched an investigation into suspected sabotage after damage was discovered on an undersea cable in the Baltic Sea, intensifying concerns over the ... Read More

EC approves CSL and Arcturus Therapeutics’ KOSTAIVE mRNA COVID-19 vaccine

Pallavi Madhiraju- February 16, 2025 0

The European Commission (EC) has officially granted COVID-19 vaccine approval for KOSTAIVE, the first self-amplifying mRNA vaccine for COVID-19, developed by CSL and Arcturus Therapeutics. ... Read More

123...1110 / 105 Posts